Viewing nowMontelukast Chewable Tablets 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

MFDS item code 201907082 · Approved 2019.10.04 · Insurance code 658603900
Prevention and long-term treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
This medication helps prevent asthma and provides continuous treatment for symptoms. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
Take this drug once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. To take, pour the contents of 1 sachet into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire dose immediately (within 15 minutes). Do not leave this drug suspended in water for an extended period.
Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue and, once it disintegrates, take without water once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue and, once it disintegrates, take without water once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this drug 1 hour before or 2 hours after a meal. Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months to under 2 years: Administer 4 mg of this drug orally once daily in the evening. The efficacy and safety of this drug for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. The efficacy and safety of this drug for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months to under 2 years: Administer 4mg of this drug orally once daily. The efficacy and safety of this drug for perennial allergic rhinitis have not been established in infants under 6 months of age. The 4 mg granules of this drug may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food at or below room temperature, such as infant food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix the granules with infant food, breast milk, or food, or take the entire dose as is. Do not leave this drug mixed with infant food, breast milk, or food for an extended period; discard any remaining portion. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This drug may be taken without regard to meals.
This medication is used for the treatment of asthma and allergic rhinitis. During the treatment with this medication, psychiatric symptoms may occur; therefore, both patients and guardians should closely monitor for symptoms such as anxiety, depression, aggressive behavior, sleep disturbances, and suicidal thoughts. If any of these symptoms occur, discontinue use immediately and consult a physician. This medication contains the artificial sweetener aspartame, which should be avoided by patients with phenylketonuria, and there are daily intake limits for aspartame. Since it contains lactose, patients with genetic problems such as galactose intolerance or lactase deficiency should not use this medication. This medication is not intended for the treatment of acute asthma attacks, so appropriate emergency medications should be used in case of sudden symptoms. Additionally, patients who are hypersensitive to aspirin or non-steroidal anti-inflammatory drugs should avoid taking these medications while using this one. During use, dosages of other asthma medications should be adjusted according to the physician's instructions, and should not be discontinued or changed arbitrarily. This medication should be given to pregnant women only if necessary, and caution is needed for breastfeeding mothers. In case of overdose, there is no specific antidote; therefore, general symptomatic treatment and clinical observation are necessary. Children and elderly patients can also use this medication, but safety and efficacy may vary according to age, so physician instructions must be followed. When storing this medication, keep it out of the reach of children, and it is advisable not to change the container. It is important to inform the physician immediately if new symptoms or adverse reactions occur during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. Additionally, it is important to store the medication in a sealed container to prevent exposure to air.
Pink chewable tablets with a convex shape on both sides.
28 tablets/PTP [7 tablets/PTPX4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.